TY - JOUR
T1 - International periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis syndrome cohort
T2 - Description of distinct phenotypes in 301 patients
AU - Hofer, Michaël
AU - Pillet, Pascal
AU - Cochard, Marie Madeleine
AU - Berg, Stefan
AU - Krol, Petra
AU - Kone-paut, Isabelle
AU - Rigante, Donato
AU - Hentgen, Véronique
AU - Anton, Jordi
AU - Brik, Riva
AU - Neven, Bénédicte
AU - Touitou, Isabelle
AU - Kaiser, Daniela
AU - Duquesne, Agnès
AU - Wouters, Carine
AU - Gattorno, Marco
PY - 2014
Y1 - 2014
N2 - Objectives: The aims of this study were to describe the clinical features of periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) and identify distinct phenotypes in a large cohort of patients from different countries. Methods: We established a web-based multicentre cohort through an international collaboration within the periodic fevers working party of the Pediatric Rheumatology European Society (PReS). The inclusion criterion was a diagnosis of PFAPA given by an experienced paediatric rheumatologist participating in an international working group on periodic fever syndromes. Results: Of the 301 patients included from the 15 centres, 271 had pharyngitis, 236 cervical adenitis, 171 oral aphthosis and 132 with all three clinical features. A total of 228 patients presented with additional symptoms (131 gastrointestinal symptoms, 86 arthralgias and/or myalgias, 36 skin rashes, 8 neurological symptoms). Thirty-one patients had disease onset after 5 years and they reported more additional symptoms. A positive family history for recurrent fever or recurrent tonsillitis was found in 81 patients (26.9%). Genetic testing for monogenic periodic fever syndromes was performed on 111 patients, who reported fewer occurrences of oral aphthosis or additional symptoms. Twenty-four patients reported symptoms (oral aphthosis and malaise) outside the flares. The CRP was >50 mg/l in the majority (131/190) of the patients tested during the fever. Conclusion: We describe the largest cohort of PFAPA patients presented so far. We confirm that PFAPA may present with varied clinical manifestations and we show the limitations of the commonly used diagnostic criteria. Based on detailed analysis of this cohort, a consensus definition of PFAPA with better-defined criteria should be proposed.
AB - Objectives: The aims of this study were to describe the clinical features of periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) and identify distinct phenotypes in a large cohort of patients from different countries. Methods: We established a web-based multicentre cohort through an international collaboration within the periodic fevers working party of the Pediatric Rheumatology European Society (PReS). The inclusion criterion was a diagnosis of PFAPA given by an experienced paediatric rheumatologist participating in an international working group on periodic fever syndromes. Results: Of the 301 patients included from the 15 centres, 271 had pharyngitis, 236 cervical adenitis, 171 oral aphthosis and 132 with all three clinical features. A total of 228 patients presented with additional symptoms (131 gastrointestinal symptoms, 86 arthralgias and/or myalgias, 36 skin rashes, 8 neurological symptoms). Thirty-one patients had disease onset after 5 years and they reported more additional symptoms. A positive family history for recurrent fever or recurrent tonsillitis was found in 81 patients (26.9%). Genetic testing for monogenic periodic fever syndromes was performed on 111 patients, who reported fewer occurrences of oral aphthosis or additional symptoms. Twenty-four patients reported symptoms (oral aphthosis and malaise) outside the flares. The CRP was >50 mg/l in the majority (131/190) of the patients tested during the fever. Conclusion: We describe the largest cohort of PFAPA patients presented so far. We confirm that PFAPA may present with varied clinical manifestations and we show the limitations of the commonly used diagnostic criteria. Based on detailed analysis of this cohort, a consensus definition of PFAPA with better-defined criteria should be proposed.
KW - Autoinflammatory disease
KW - Child
KW - Cohort
KW - PFAPA
KW - Recurrent fever
UR - http://www.scopus.com/inward/record.url?scp=84900791985&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84900791985&partnerID=8YFLogxK
U2 - 10.1093/rheumatology/ket460
DO - 10.1093/rheumatology/ket460
M3 - Article
C2 - 24505122
AN - SCOPUS:84900791985
SN - 1462-0324
VL - 53
SP - 1125
EP - 1129
JO - Rheumatology
JF - Rheumatology
IS - 6
M1 - ket460
ER -